Lakefront Biotherapeutics | GLPG - Deudores Comerciales





Deudores Comerciales Cambio Fecha
argenx SE USD 2.01B 352.94M 2026-06
AstraZeneca USD 18.86B 972M 2026-06
Biogen USD 1.79B 76.6M 2026-03
Genmab DKK 1.17B 119M 2025-12
Gilead Sciences USD 4.74B 172M 2026-03
GlaxoSmithKline GBP 8.07B 137M 2026-06
GRIFOLS EUR 958M 106M 2026-03
Hikma Pharmaceutical USD 1.08B 27M 2025-12
Incyte USD 1.13B 73.7M 2026-06
Merck EUR 4.81B 373M 2026-03
Neurocrine Biosciences USD 768.1M 81.3M 2026-03
Novartis USD 9.85B 252M 2026-06
Roche Holding CHF 13.34B 1.44B 2026-06
Sanofi EUR 482M 85M 2026-03
UCB EUR 1.97B 54M 2025-12
Vertex Pharmaceuticals USD 2B 56.7M 2026-03